SURG CEO Cox buys 15,073 shares at $2.75; reiterates buy discipline amid -55.6% revenue decline and $-7.6M net loss.
Cox Kevin Brian, CEO and Chairman, purchased 15,073 shares at $2.75 on 2025-05-16, expanding his holdings to 5,785,163 shares. This represents a modest 0.3% addition to his stake, executed at a price 5.5% below the current $2.91 level. The transaction mirrors his prior SURG buy from 2023-08-15, which delivered a 90d return of +18.2%, demonstrating consistent timing discipline at this ticker. However, the buy occurs within a deteriorating operational backdrop: FY revenue contracted -55.6% year-over-year to $10,577,429.00 (latest quarter), and the company posted a full-year net loss of $-7,635,084.00. The insider's cross-ticker track record shows 1 prior buy with a 90d average return of +18.2% and 100% win rate, but the small position increment and unprofitable state make this acquisition a narrow data point requiring deeper operational context to assess conviction or capital allocation priority.